Mental patients and their profile of compliance with psychopharmacological treatment

被引:0
|
作者
Cardoso, Lucilene [1 ]
Frari Galera, Sueli Aparecida [2 ]
机构
[1] Univ Sao Paulo, Ribeirao Preto Coll Nursing, Psychiat Nursing Grad Program, Sao Paulo, Brazil
[2] Univ Sao Paulo, Ribeirao Preto Coll Nursing, Psychiat Nursing & Human Sci Dept, Sao Paulo, Brazil
关键词
Mentaly ill persons; Patient compliance; Treatment refusal; Community psychiatry; Psychiatric nursing; SCHIZOPHRENIA; MEDICATION; ADHERENCE;
D O I
暂无
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
Non-compliance with drug-based treatment is a complex and universal phenomenon that develops gradually during psychiatric treatments, and is related to disease aggravation. The purpose of this study was to describe the profile of using a given medication in the clientele of a community mental healthcare service and its characteristics. We performed a retrospective study in the medical records of patients who used Haloperidol Decanoate in a period of 1 year and 8 months. 167 medical records were analyzed. 60% of the patients presented irregular use of medication, which reflects in high risks of relapse and re-hospitalizations. This profile configures low compliance with the prescribed drug treatment, leading to reflections about which factors influence this behavior and which measures could be implemented in the maintenance of extra-hospital treatment for these patients.
引用
收藏
页码:154 / 160
页数:7
相关论文
共 50 条
  • [1] Psychopharmacological treatment of delirium to restore mental capacity
    Bostwick, JM
    Masterson, BJ
    PSYCHOSOMATICS, 1998, 39 (02) : 112 - 117
  • [2] Psychopharmacological treatment of suicidal patients
    Goldblatt, MJ
    Silverman, MM
    REVIEW OF SUICIDOLOGY, 2000, 2000, : 140 - 156
  • [3] PSYCHOPHARMACOLOGICAL TREATMENT IN ELDERLY PATIENTS
    RAVIZZA, L
    INTERNATIONAL JOURNAL OF NEUROSCIENCE, 1986, 31 (1-4) : 242 - 242
  • [4] Postmenopausal osteoporotic patients profile and treatment compliance: Ostepi study
    Blotman, F.
    Avouac, B.
    Cortet, B.
    Hilliquin, P.
    Pouchain, D.
    Allaert, F. A.
    Gaudin, A. F.
    El Hasnaoui, A.
    OSTEOPOROSIS INTERNATIONAL, 2006, 17 : S78 - S78
  • [5] Profile of hypertensive patients: biosocial characteristics, knowledge, and treatment compliance
    Jesus, Elaine dos Santos
    de Oliveira Augusto, Monica Aparecida
    Gusmao, Josiane
    Mion Junior, Decio
    Ortega, Katia
    Geraldo Pierin, Angela Maria
    ACTA PAULISTA DE ENFERMAGEM, 2008, 21 (01) : 59 - 65
  • [6] PSYCHOPHARMACOLOGICAL PROFILE OF CLENBUTEROL
    FRANCES, H
    PONCELET, M
    DANTI, S
    GOLDSCHMIDT, P
    SIMON, P
    DRUG DEVELOPMENT RESEARCH, 1983, 3 (04) : 349 - 356
  • [7] Psychopharmacological profile of venlafaxine
    Bourin, M
    ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE, 1999, 25 : 21 - 22
  • [8] PSYCHOPHARMACOLOGICAL PROFILE OF MESTEROLONE
    BARAN, L
    PRZEGALINSKI, E
    POLISH JOURNAL OF PHARMACOLOGY AND PHARMACY, 1981, 33 (03): : 299 - 303
  • [9] Psychopharmacological profile of venlafaxine
    Puech, A
    ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE, 1999, 25 : 23 - 23
  • [10] Psychopharmacological treatment of patients with HIV and AIDS
    Ferrando, SJ
    Wapenyi, C
    PSYCHIATRIC QUARTERLY, 2002, 73 (01) : 33 - 49